Sucampo, Takeda obtain expanded approval for Amitiza

04/23/2013 | CNBC

The FDA has granted Sucampo Pharmaceuticals and Takeda Pharmaceuticals expanded approval for their Amitiza drug to treat constipation from opioids used for chronic pain. Forty percent or more of patients who use opioids for chronic pain not associated with cancer experience constipation, the companies said.

View Full Article in:

CNBC

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR